WPRIM Management System> DCMS> Journal of Experimental Hematology> 2008> 16> 5

Volume: 16 Issue: 5

1. Advance of study on demethylation in leukemia - review. Page:1247—1250
2. Gene atm and chronic lymphocytic leukemia - review. Page:1242—1246
3. Recent advances on application of small RNA in research for hematological malignancies - review. Page:1237—1241
4. Recent progress of study on mechanism of immune thrombocytopenic purpura and its clinical treatment - review. Page:1232—1236
5. Research advance of notch signal in ex vivo expansion of hematopoietic progenitor cells - review. Page:1227—1231
6. Clinical significance of Helicobacter pylori in pathogenesis of idiopathic thrombocytopenic purpura. Page:1222—1226
7. Curative effect of rhIL-11 on 26 patients with chromic idiopathic thrombocytopenic purpura. Page:1219—1221
8. Candida tropicalis arthritis in a patient with acute leukemia. Page:1215—1218
9. Acute myeloid leukemia with the morphological characteristics of prolymphocytic leukemia. Page:1211—1214
10. Analysis of false-positive reaction for bacterial detection of blood samples with the automated microbial detection system BacT/ALERT 3D. Page:1207—1210
11. Effect of prefreezing parameters on human platelet cryopreservation. Page:1201—1206
12. Cryopreservation of platelets after storage at normal temperature for 3 days and its clinical practice. Page:1196—1200
13. Identification of the hemolytic transfusion reaction caused by lewis antibody using serological and molecular biological methods. Page:1192—1195
14. Changes of platelet aggregation function of apheresis collected platelets and soluble P-selectin during storage. Page:1188—1191
15. Cytokine contents in single donor platelets during storage. Page:1185—1187
16. Mechanism of erythrocyte phosphatidylserine exposure induced by high concentrated glucose. Page:1181—1184
17. Dynamic change of plasma prethrombotic state molecular marker levels in perioperative period of patients and its clinical significance. Page:1177—1180
18. GFP used as a reporter system for optimization of K562 cell transfection. Page:1174—1176
19. Construction and selection of the most efficient siRNA interfering plasmid specific to mouse Qa-1 gene. Page:1170—1173
20. Regulatory effect of Egr-1 promoter sequences induced by doxorubicin in transcriptional targeting on expression of GM-CSF gene. Page:1165—1169
21. Establishment of the method to induce and measure human IL-2 in vitro. Page:1162—1164
22. Expression of CIITA Gene in five human cell lines and its significance. Page:1158—1161
23. Diagnostic significance of NK cell activity and soluble CD25 level in serum from patients with secondary hemophagocytic lymphohistiocytosis. Page:1154—1157
24. Biological activity of DC-CIK cells and its effect against leukemia cells in vitro. Page:1150—1153
25. Effect of PD-L1 blockade on function of dendritic cells derived from chronic myelocytic leukemia. Page:1146—1149
26. Induction of dendritic cells derived from acute promyelocytic leukemia cells by all trans retinoic acid. Page:1140—1145
27. Transforming growth factor beta alleviates acute graft-versus-host-disease after allogeneic bone marrow transplantation in murine model. Page:1135—1139
28. Immune reconstitution after allogeneic peripheral blood stem cell transplantation. Page:1130—1134
29. An effective method for T-cell and B-cell simultaneous depletion in vitro from mobilized peripheral blood stem/progenitor cell graft for haploidentical transplantation. Page:1126—1129
30. Ex vivo expansion of megakaryocyte progenitors from human umbilical cord blood CD34(+) cells. Page:1121—1125
31. Immunoregulatory effect of mesenchymal stem cells on active T lymphocytes. Page:1116—1120
32. Differentiation of bone marrow derived from mesenchymal stem cells into cardiomyocyte-like cells induced by co-culture with rat myocardial cells. Page:1111—1115
33. Megakaryocytic dysplasia and leukemia associated phenotype in elderly patients with acute myeloid leukemia. Page:1107—1110
34. Short-term curative effect of amifostine combined with rhbeta-EPO on patients with pure erythroid aplasia. Page:1103—1106
35. Expression of hematopoietic cytokines EPO, SCF and GM-CSF in bone marrow cells of patients with chronic aplastic anemia. Page:1100—1102
36. Analysis of single nucleotide polymorphism in the human beta-globin gene of patients with minor beta-thalassemia from Wenzhou. Page:1096—1099
37. Analysis of lymphocyte immune abnormality in 52 cases of children idiopathic aplastic anemia. Page:1091—1095
38. Expression of tumor suppressor gene pten in patients with myelodysplastic syndrome and acute myeloid leukemia. Page:1086—1090
39. Expressions of costimulatory molecules on CD3(+)CD4(+) T cells in myelodysplastic syndrome. Page:1082—1085
40. Expression of survivin and NF-kappaB in peripheral T-cell lymphoma and its significance. Page:1079—1081
41. Demethylation and transcription of p16 gene in malignant lymphoma cell line CA46 induced by EGCG. Page:1073—1078
42. Antitumor effect of anti-brain derived neurotrophic factor monoclonal antibody in human multiple myeloma xenograft animal model. Page:1069—1072
43. Arsenic trioxide induces socs-1 gene demethylation in myeloma cell lines. Page:1064—1068
44. Phenylhexyl isothiocyanate reducing U266 cell line methylation level of p16 gene. Page:1060—1063
45. Apoptosis of the adriamycin-resistant leukemia cell line induced by the recombinant mutant human TNF-related apoptosis-inducing ligand combined with arsenic trioxide. Page:1055—1059
46. Change of oxygen free radical in reversing multidrug-resistance of human leukemic cell line HL-60/ADM by cyclosporin A. Page:1050—1054
47. Mechanism reversing MDR of K562/A02 by garlicin combined with erythromycin. Page:1044—1049
48. Effect of a novel tyrosine kinase inhibitor HHGV678 on growth inhibition of Bcr-Abl wild type and IM-resistant cell lines in vitro. Page:1039—1043
49. Inhibition effect of hedyotis diffusa wild injection on HL-60 cells and its mechanism. Page:1035—1038
50. Molecular mechanism underlying differentiation of HL-60 cells induced by hexamethylene bisacetamide. Page:1030—1034
51. Relationship between apoptotic effect of Resveratrol on KG-1 cells and expression of bcl-2/bax. Page:1026—1029
52. Changes of activity and expression of protein phosphatase type 2A during the apoptosis of NB4 and MR2 cells induced by arsenic trioxide. Page:1021—1025
53. Inducing-apoptosis effect of bortezomib on acute monocytic leukemia cell SHI-1 and its influence on expressions of Bcl2l12, Bcl-2 and Bax genes. Page:1016—1020
54. Signal pathway in apoptosis of K562 cells induced by STI571. Page:1010—1015
55. Effects of proteasome inhibitor bortezomib on NF-kappaB activity and ICAM-1 mRNA expression of K562 cells. Page:1006—1009
56. Efficiency of GHA priming chemotherapy on patients with refractory acute myeloid leukemia and myelodysplastic syndrome and its relationship with expression of costimulatory molecule B7.1. Page:1002—1005
57. Cytogenetic analysis on 135 cases of chronic myelogenous leukemias with non-simple Philadelphia chromosome. Page:997—1001
58. Analysis of chromosome-8 aberrations in myeloid malignancies with complex chromosome abnormalities. Page:993—996
59. Preliminary study on Id4 as a reporter for all patients before relapse. Page:990—992